IRX5 promotes metastasis via RHOA signaling in colorectal cancer (Zhu et al., 2019) and regulates WNT/β-catenin pathways, which intersect with FAT1-mediated Hippo signaling (Holmquist Mengelbier et al., 2019). Here, IRX5 is linked to colorectal cancer.